Evidence map›Paper›PMID 30188790›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Dose Reduction May Jeopardize Efficacy of Abiraterone Acetate.

F J Sherida H Woei-A-Jin, Tine Van Nieuwenhuyse, Nielka P van Erp, Benoit Beuselinck, Stephanie Stroobants, Dirk Jan A R Moes, Susanne Osanto, Isabel Spriet

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Dose optimization during drug development: whether and when to optimize.Journal of the National Cancer Institute · 2023
    Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

F J Sherida H Woei-A-JinF.J. Sherida H. Woei-A-Jin, University Hospitals Leuven, Leuven, Belgium; and Leiden University Medical Center, Leiden, the Netherlands; Tine Van Nieuwenhuyse, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium; Nielka P. van Erp, Radboud University Medical Center, Nijmegen, the Netherlands; Benoit Beuselinck and Stephanie Stroobants, University Hospitals Leuven, Leuven, Belgium; Dirk Jan A.R. Moes and Susanne Osanto, Leiden University Medical Center, Leiden, the Netherlands; and Isabel Spriet, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium.
Tine Van NieuwenhuyseF.J. Sherida H. Woei-A-Jin, University Hospitals Leuven, Leuven, Belgium; and Leiden University Medical Center, Leiden, the Netherlands; Tine Van Nieuwenhuyse, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium; Nielka P. van Erp, Radboud University Medical Center, Nijmegen, the Netherlands; Benoit Beuselinck and Stephanie Stroobants, University Hospitals Leuven, Leuven, Belgium; Dirk Jan A.R. Moes and Susanne Osanto, Leiden University Medical Center, Leiden, the Netherlands; and Isabel Spriet, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium.
Nielka P van ErpF.J. Sherida H. Woei-A-Jin, University Hospitals Leuven, Leuven, Belgium; and Leiden University Medical Center, Leiden, the Netherlands; Tine Van Nieuwenhuyse, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium; Nielka P. van Erp, Radboud University Medical Center, Nijmegen, the Netherlands; Benoit Beuselinck and Stephanie Stroobants, University Hospitals Leuven, Leuven, Belgium; Dirk Jan A.R. Moes and Susanne Osanto, Leiden University Medical Center, Leiden, the Netherlands; and Isabel Spriet, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium.
Benoit BeuselinckF.J. Sherida H. Woei-A-Jin, University Hospitals Leuven, Leuven, Belgium; and Leiden University Medical Center, Leiden, the Netherlands; Tine Van Nieuwenhuyse, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium; Nielka P. van Erp, Radboud University Medical Center, Nijmegen, the Netherlands; Benoit Beuselinck and Stephanie Stroobants, University Hospitals Leuven, Leuven, Belgium; Dirk Jan A.R. Moes and Susanne Osanto, Leiden University Medical Center, Leiden, the Netherlands; and Isabel Spriet, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium.
Stephanie StroobantsF.J. Sherida H. Woei-A-Jin, University Hospitals Leuven, Leuven, Belgium; and Leiden University Medical Center, Leiden, the Netherlands; Tine Van Nieuwenhuyse, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium; Nielka P. van Erp, Radboud University Medical Center, Nijmegen, the Netherlands; Benoit Beuselinck and Stephanie Stroobants, University Hospitals Leuven, Leuven, Belgium; Dirk Jan A.R. Moes and Susanne Osanto, Leiden University Medical Center, Leiden, the Netherlands; and Isabel Spriet, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium.
Dirk Jan A R MoesF.J. Sherida H. Woei-A-Jin, University Hospitals Leuven, Leuven, Belgium; and Leiden University Medical Center, Leiden, the Netherlands; Tine Van Nieuwenhuyse, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium; Nielka P. van Erp, Radboud University Medical Center, Nijmegen, the Netherlands; Benoit Beuselinck and Stephanie Stroobants, University Hospitals Leuven, Leuven, Belgium; Dirk Jan A.R. Moes and Susanne Osanto, Leiden University Medical Center, Leiden, the Netherlands; and Isabel Spriet, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium.
Susanne OsantoF.J. Sherida H. Woei-A-Jin, University Hospitals Leuven, Leuven, Belgium; and Leiden University Medical Center, Leiden, the Netherlands; Tine Van Nieuwenhuyse, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium; Nielka P. van Erp, Radboud University Medical Center, Nijmegen, the Netherlands; Benoit Beuselinck and Stephanie Stroobants, University Hospitals Leuven, Leuven, Belgium; Dirk Jan A.R. Moes and Susanne Osanto, Leiden University Medical Center, Leiden, the Netherlands; and Isabel Spriet, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium.
Isabel SprietF.J. Sherida H. Woei-A-Jin, University Hospitals Leuven, Leuven, Belgium; and Leiden University Medical Center, Leiden, the Netherlands; Tine Van Nieuwenhuyse, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium; Nielka P. van Erp, Radboud University Medical Center, Nijmegen, the Netherlands; Benoit Beuselinck and Stephanie Stroobants, University Hospitals Leuven, Leuven, Belgium; Dirk Jan A.R. Moes and Susanne Osanto, Leiden University Medical Center, Leiden, the Netherlands; and Isabel Spriet, University Hospitals Leuven; and Katholieke Universiteit Leuven, Leuven, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Abiraterone AcetateProstatic Neoplasms, Castration-ResistantAndrostenesHumansMaleProspective StudiesabirateroneAbiraterone AcetateAndrostenes

Identifiers

PMID30188790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.